Difference between revisions of "Part:BBa K2440019"
(→Usage and Biology) |
(→Experimental Validation) |
||
Line 29: | Line 29: | ||
This part is sequenced as correct after construction. | This part is sequenced as correct after construction. | ||
+ | |||
+ | |||
+ | ==Reference== | ||
+ | |||
+ | |||
+ | 1.Identification of new microRNAs in paired normal and tumor breast tissue suggests a dual role for the ERBB2/Her2 gene. Persson H, Kvist A, Rego N, Staaf J, Vallon-Christersson J, Luts L, Loman N, Jonsson G, Naya H, Hoglund M, Borg A, Rovira C Cancer Res. 71:78-86(2011). | ||
+ | |||
+ | 2.NF-κB target microRNAs and their target genes in TNFα-stimulated HeLa cells. Zhou F, Wang W, Xing Y, Wang T, Xu X, Wang J. |
Latest revision as of 01:00, 1 November 2017
miR-2467 target sequence
It is the target sequence of miR-2467, a modularized DNA part from a set of chemically synthetic oligo DNA library.
Usage and Biology
MiRNA locker assembled by using this modularized DNA part was able to bind miR-2467 in an Ago2 dependent manner, that is, knockdown of miR-2467 was achieved by transfecting cells with miRNA locker.
Hsa-miR-2467-5p was firstly found in human breast tissue. It may be applied in tumor identity with other miRNAs.1
By using ChIP-Seq, Genechip and miRNA-Seq techniques, hsa-miR-2467-5p was identified as a NF-κB target miRNA in TNFα-stimulated HeLa Cells.2
Sequence and Features
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Experimental Validation
This part is sequenced as correct after construction.
Reference
1.Identification of new microRNAs in paired normal and tumor breast tissue suggests a dual role for the ERBB2/Her2 gene. Persson H, Kvist A, Rego N, Staaf J, Vallon-Christersson J, Luts L, Loman N, Jonsson G, Naya H, Hoglund M, Borg A, Rovira C Cancer Res. 71:78-86(2011).
2.NF-κB target microRNAs and their target genes in TNFα-stimulated HeLa cells. Zhou F, Wang W, Xing Y, Wang T, Xu X, Wang J.